Pressure BioSciences (PBIO) Reports Q2 Loss of $0.72
More News related to PBIO
- Pressure BioSciences, Inc. Announces Restructuring, Significant Cost Reduction Initiatives, and Sharpened Focus
- Pressure BioSciences (PBIO) Reports a Q3 Loss, Comments on Outlook
- Pressure BioSciences, Inc. Reports Record Third Quarter 2008 Financial Results and Provides Business Update
- Pressure BioSciences, Inc. to Discuss Third Quarter 2008 Financial Results and Provide Business Update
- Pressure BioSciences (PBIO) Comments on Favorable Data Presented by Scientists at Amgen (AMGN)
More News related to Earnings
- Quanex (NX) Reports Q4 EPS of $0.32, Beats by 1c
- Culp (CFI) Reports Large Q2 Loss
- Versant (VSNT) Reports Q4 EPS of $0.59; Guides FY09
- HLS Systems (HOLI) Profits and Revenues Rise; Reiterates Guidance
- Ulta (ULTA) Reports In-Line Q3 Earnings; Guides Q4, FY08
Pressure BioSciences (Nasdaq: PBIO) reports a Q2 loss of $0.72, versus the analyst estimate of ($0.64). Revenues for the quarter were $120.2K, versus the consensus of $160K.
Pressure BioSciences, Inc., a life sciences company, engages in the research, development, and commercialization of pressure cycling technology (PCT) that uses cycles of hydrostatic pressure between ambient and ultra-high levels to control bio-molecular interactions.
Related Categories
EarningsStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
